He has clinical and research expertise in the myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and allogeneic hematopoietic cell transplant. Dr. Cogle leads a clinical and laboratory research group that translates fundamental science discoveries into new treatments for patients. Dr. Cogle’s goal is to find cures for MDS and leukemia, educate patients and providers about these diseases, educate policy makers that blood cancers are a public health concern, and advocate for patients to get the best care possible.